moringa acquisition corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. moringa intends to focus its search on israel-related technology companies.
Company profile
Ticker
MACA, MACAU
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
MACA stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
15 May 24
8-K
Entry into a Material Definitive Agreement
3 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Feb 24
8-K
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
26 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
22 Aug 23
DEFA14A
Additional proxy soliciting materials
16 Aug 23
DEFA14A
Additional proxy soliciting materials
15 Aug 23
8-K
Moringa Acquisition Corp Announces Contribution to Trust Account In Connection with Proposed Extension
15 Aug 23
Latest ownership filings
SC 13G/A
Radcliffe Capital Management, L.P.
14 Feb 24
SC 13G/A
ARISTEIA CAPITAL, L.L.C.
12 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13G
Yakira Capital Management, Inc.
26 Jan 24
SC 13G/A
GLAZER CAPITAL, LLC
11 Sep 23
4
Change in insider ownership
24 Aug 23
3
Sander Gerber
5 Apr 23
SC 13G/A
GLAZER CAPITAL, LLC
10 Mar 23
SC 13G
Radcliffe Capital Management, L.P.
16 Feb 23
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.82 mm | 5.82 mm | 5.82 mm | 5.82 mm | 5.82 mm | 5.82 mm |
Cash burn (monthly) | (no burn) | 1.76 mm | 178.76 k | 101.84 k | 88.52 k | 40.92 k |
Cash used (since last report) | n/a | 2.79 mm | 283.87 k | 161.72 k | 140.57 k | 64.98 k |
Cash remaining | n/a | 3.02 mm | 5.53 mm | 5.65 mm | 5.67 mm | 5.75 mm |
Runway (months of cash) | n/a | 1.7 | 30.9 | 55.5 | 64.1 | 140.5 |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 35 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 38.84 mm |
Total shares | 3.94 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Moringa Sponsor US | 3.23 mm | $31.25 mm |
Linden Capital | 675.00 k | $6.53 mm |
Dupont Capital Management | 32.50 k | $1.06 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Aug 23 | Hudson Bay Capital Management | Class A Ordinary Shares, par value $0.0001 per share | Other | Dispose J | Yes | No | 10.6 | 401,271 | 4.25 mm | 0 |